Illumina

Illumina

Yahoo Finance • yesterday

Cathie Wood Loads Up on SpaceX, Meta, Eli Lilly and Circle Group

This article first appeared on GuruFocus. Cathie Wood's ARK Invest increased positions in several technology, healthcare and digital asset companies during the week ended July 10, while reducing holdings in select semiconductor and genomi... Full story

Yahoo Finance • yesterday

Cathie Wood reshuffles portfolio ahead of Q2, buys SpaceX, Eli Lilly, Meta; pares AMD, Roku

Cathie Wood's ARK Invest's largest purchase during the last week by value was Elon Musk's Space Exploration Technologies (SPCX [https://seekingalpha.com/symbol/SPCX]), adding a combined 349K shares across ARKK, ARKQ, ARKW and ARKX for ~$52... Full story

Yahoo Finance • 4 days ago

Q2 watchlist: Healthcare stocks with perfect EPS revision scores

[Heart Health Concept] Eoneren/E+ via Getty Images As Q2 2026 earnings season approaches, healthcare stocks are drawing investor attention as markets assess demand across care delivery, diagnostics, life sciences, pharmaceuticals, medical... Full story

Yahoo Finance • 9 days ago

Citi's picks and pans for H2 '26: REITs, tech, consumer, health

[Citibank headquarters in Canary Wharf, London, UK] VV Shots Citi released its roadmap for the second half of 2026, including a macro-to-micro view of equity sectors. "Our recently revised S&P 500 (SPY [https://seekingalpha.com/symbol/SP... Full story

Yahoo Finance • 14 days ago

Why Illumina (ILMN) Stock Is Down Today

Why Illumina (ILMN) Stock Is Down Today What Happened? Shares of genomics company Illumina (NASDAQ:ILMN) fell 1.9% in the afternoon session after Swiss drugmaker Roche launched a next-generation gene sequencing machine, taking aim at the... Full story

Yahoo Finance • 15 days ago

Global Hematologic Malignancies Testing Market Size/Share Worth USD 12.47 Billion by 2035 at a 14.4% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)

Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Hematologic Malignancies Testing Market size & share revenue was valued at approximat... Full story

Yahoo Finance • 19 days ago

Alger Russell Innovation Index Updates for Second Quarter 2026

NEW YORK, June 25, 2026 /PRNewswire/ -- Fred Alger Management, LLC ("Alger"), a privately held growth equity investment manager, today announced the quarterly rebalancing of the Alger Russell Innovation Index ("Index"). Following the close... Full story

Yahoo Finance • 20 days ago

Why Illumina (ILMN) Stock Is Trading Up Today

Why Illumina (ILMN) Stock Is Trading Up Today What Happened? Shares of genomics company Illumina (NASDAQ:ILMN) jumped 6.6% in the morning session after it appointed a high-profile Eli Lilly executive to its board and a price target incre... Full story

Yahoo Finance • 21 days ago

Adding Eli Lilly’s R&D Chief to the Board Might Change The Case For Investing In Illumina (ILMN)

Illumina, Inc. recently expanded its Board from nine to ten members and appointed Daniel M. Skovronsky, M.D., Ph.D., Chief Scientific and Product Officer at Eli Lilly and President of Lilly Research Laboratories, as an independent director... Full story

Yahoo Finance • 21 days ago

Daniel M. Skovronsky, MD, PhD, appointed to Illumina's Board of Directors

Eli Lilly and Company's Chief Scientific and Product Officer brings pharmaceutical R&D and scientific leadership perspective to Illumina's Board SAN DIEGO, June 23, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced the ap... Full story

Yahoo Finance • 28 days ago

1 Unpopular Stock That Deserves Some Love and 2 Facing Challenges

1 Unpopular Stock That Deserves Some Love and 2 Facing Challenges Wall Street's bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate r... Full story

Yahoo Finance • last month

Stocks Settle Sharply Lower on Escalating Middle East Tensions

The S&P 500 Index ($SPX) (SPY) on Wednesday closed down -1.62%, the Dow Jones Industrial Average ($DOWI) (DIA) closed down -1.87%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed down -1.98%.  June E-mini S&P futures (ESM26) fell -1.62%, and... Full story

Yahoo Finance • last month

Illumina upgraded to overweight at JPMorgan on clinical demand outlook

Investing.com -- Illumina received a bullish rating upgrade from JPMorgan, which raised its recommendation to Overweight from Neutral and lifted its December 2026 price target to $185 from $125, citing growing confidence in the DNA sequenc... Full story

Yahoo Finance • last month

Stocks Resume Decline as Chipmakers and AI Companies Fall

The S&P 500 Index ($SPX) (SPY) today is down -0.61%, the Dow Jones Industrial Average ($DOWI) (DIA) is down -0.88%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -0.80%.  June E-mini S&P futures (ESM26) are down -0.71%, and June E-mini Na... Full story

Yahoo Finance • last month

Stocks Fall on Weakness in Tech and Trucking Companies

The S&P 500 Index ($SPX) (SPY) today is down -0.28%, the Dow Jones Industrial Average ($DOWI) (DIA) is down -0.38%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -0.28%.  June E-mini S&P futures (ESM26) are down -0.25%, and June E-mini Na... Full story

Yahoo Finance • last month

Nike downgraded, Oscar Health upgraded: Wall Street's top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Barclays upgraded Oscar Health(OSCR) t... Full story

Yahoo Finance • last month

Samsung Electronics invests $175 million in Element Biosciences' Series E funding round

June 9 (Reuters) - Privately held Element Biosciences said on Tuesday it had raised funds ‌in an upsized Series E round, ‌including $175 million from longtime investor Samsung Electronics, to expand commercialization of ​its genetic testin... Full story

Yahoo Finance • last month

Is Grail Stock a Bad-News Buy After Its Recent Pullback?

Grail's (NASDAQ: GRAL) stock closed at a record high of $116.06 in January. That marked a 732% gain from its $13.95 opening price following its spin-off from Illumina (NASDAQ: ILMN) in June 2024. But as of this writing, it trades at about... Full story

Yahoo Finance • last month

GRAIL, Inc. (GRAL): One of the Best Stock Picks of Jeff Bezos

We just covered the Jeff Bezos Stock Portfolio: Top 10 Stock Picks and GRAIL, Inc. (NASDAQ:GRAL) ranks 8th on this list. The interest of Jeff Bezos in GRAIL, Inc. (NASDAQ:GRAL) can be understood in context of the history of Bezos as a bac... Full story

Yahoo Finance • 2 months ago

3 Reasons to Sell ILMN and 1 Stock to Buy Instead

Illumina has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 15% to $140.33 per share while the index has gained 13.3%. Is there a buying opportunity in Illumi... Full story